Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron and Simvastatin for Schizophrenia (ROSES)
NCT01602029Phase 2Completed
- Sponsor
- Pakistan Institute of Living and Learning
- Start
- Aug 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron, simvastatin in schizophrenia, schizoaffective disorder, Psychotic Disorder Not Otherwise Specified (PD-NOS), schizophreniform disorder, sponsored by Pakistan Institute of Living and Learning. Started Aug 2010; status: completed.
02
Drugs
ondansetronsimvastatin
03
Conditions
schizophreniaschizoaffective disorderPsychotic Disorder Not Otherwise Specified (PD-NOS)schizophreniform disorder
Beyond the preview
Go deeper on NCT01602029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602029.